"Midazolam" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
Descriptor ID |
D008874
|
MeSH Number(s) |
D03.633.100.079.080.575
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Midazolam".
Below are MeSH descriptors whose meaning is more specific than "Midazolam".
This graph shows the total number of publications written about "Midazolam" by people in this website by year, and whether "Midazolam" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 1 | 1 |
1996 | 1 | 0 | 1 |
1999 | 0 | 1 | 1 |
2001 | 1 | 0 | 1 |
2007 | 0 | 1 | 1 |
2010 | 0 | 1 | 1 |
2013 | 0 | 1 | 1 |
2014 | 1 | 0 | 1 |
2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Midazolam" by people in Profiles.
-
Patterns of benzodiazepine underdosing in the Established Status Epilepticus Treatment Trial. Epilepsia. 2021 03; 62(3):795-806.
-
The effect of ketamine on hypoventilation during deep sedation with midazolam and propofol: a randomised, double-blind, placebo-controlled trial. Eur J Anaesthesiol. 2014 Dec; 31(12):654-62.
-
Treatment of status epilepticus: an international survey of experts. Neurocrit Care. 2013 Apr; 18(2):193-200.
-
Inhibition of CYP3A by erythromycin: in vitro-in vivo correlation in rats. Drug Metab Dispos. 2010 Jan; 38(1):61-72.
-
Intensive care unit management of patients with status epilepticus. Epilepsia. 2007; 48 Suppl 8:59-60.
-
Propofol and midazolam in the treatment of refractory status epilepticus. Epilepsia. 2001 Mar; 42(3):380-6.
-
Management approaches to prolonged seizures and status epilepticus. Epilepsia. 1999; 40 Suppl 1:S59-63; discussion S64-6.
-
Propofol and midazolam in status epilepticus. Acad Emerg Med. 1996 Feb; 3(2):179.
-
New anticonvulsant drugs. Focus on flunarizine, fosphenytoin, midazolam and stiripentol. Drugs. 1994 Aug; 48(2):153-71.
-
Advances in the management of refractory status epilepticus. Crit Care Med. 1993 Jul; 21(7):955-7.